Pay in 4 interest-free payments of $5.75 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Empagliflozin in patients with heart failure, reduced ejection fraction, and volume overload: EMPEROR-reduced trial
The cardiovascular safety of incretin-based therapies: a review of the evidence
Never donate or share used pens with other patients, as residual medication and potential contamination pose serious health risks
Arokiyaraj S, Balamurugan R, Augustian P
COA available on this product page
Hypertension (High Blood Pressure) Extra body weight can cause higher blood pressure, putting additional strain on arteries and the heart, which can lead to various cardiovascular complications over time
US$ 23.17
US$ 20.90
US$ 21.70
